Stanford University
Showing 291-300 of 1,922 Results
-
Gloria M. Kardong MD, DLFAPA, DABPN
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioI attended Stanford University as an undergraduate, then returned to Stanford for my Psychiatry residency and Chief Residency. I then joined the Faculty in the Department of Psychiatry and Behavioral Sciences. I am an adjunct Clinical Associate Professor. I teach and supervise the residents in the program.
I am also on the Faculty of the Stanford Forensic Psychiatry Fellowship Program, where I teach and supervise post-graduate Fellows.
I have served an Examiner for the Medical Board of California and do Forensic Psychiatry/Expert Witness work for attorneys as part of my private practice for the past 15 years.
I have been in private practice for 35 years, including 15 years of virtual care. I am licensed in 10 states and can provide telepsychiatry services in all of those states.
Among my specialties are trauma; abuse; PTSD; women's health care-related issues, including pregnacy and post-partum issues, PMS, menopause and hormonal issues across the life span.
I also enjoy treating student health-related concerns and helping impaired professionals.
I treat all psychiatric problems for men, women, adolescents and couples. This includes anxiety, panic, bipolar disorder, ADHD, relationship issues and more. -
MD Emranul Karim
Affiliate, Medicine - Med/Infectious Diseases
Visiting Postdoctoral Scholar, Medicine - Med/Infectious DiseasesBioDr. Md. Emranul Karim is a Visiting Postdoctoral Scholar in the Department of Medicine, Division of Infectious Diseases & Geographic Medicine at Stanford University, working in the laboratory of Prof. Paul Bollyky. His current research focuses on RNA therapeutics and innovative delivery strategies for infectious and immune-mediated diseases.
Before joining Stanford, Dr. Karim was a Postdoctoral Associate in the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT), where he worked with Prof. Allan S. Myerson on developing continuous manufacturing platforms for in vitro transcription (IVT) of messenger RNA. His training at MIT provided expertise in mRNA synthesis, process optimization, and scalable manufacturing.
Dr. Karim’s broader research background lies in nanoparticle-based drug delivery and translational nanomedicine. He has extensive experience in the design and characterization of lipid nanoparticles (LNPs) and hybrid nanocarriers for nucleic acid delivery, with applications in vaccines, oncology, and regenerative medicine. He earned his Ph.D. in Biomedical Sciences from Monash University, where he developed novel nanoparticle platforms for targeted drug and gene delivery to breast cancer.
His long-term vision is to bridge RNA manufacturing and next-generation delivery technologies to accelerate the clinical translation of nucleic acid–based medicines.
